Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005313704
Wed, 11.12.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
Restrictive investment climate and low consumer confidence impact revenue and earnings performance
JENA, 11 December 2024
Carl Zeiss Meditec generated revenue of €2,066.1m in fiscal year 2023/24 (prior year: €2,089.3m), corres [ … ]
Tue, 06.08.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Restrictive investment climate and low consumer confidence impact revenue and earnings performance
JENA, 6 August 2024
Carl Zeiss Meditec generated revenue of around €1,486.5m in the first nine months of fiscal year 2023/24 (prior year: €1,509.6m) corresp [ … ]
Mon, 17.06.2024
Carl Zeiss Meditec AG
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Jena, June 17, 2024
In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313 [ … ]
Mon, 17.06.2024
Carl Zeiss Meditec AG
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Jena, June 17, 2024
In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313 [ … ]
Wed, 08.05.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed
JENA, 8 May 2024
Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior [ … ]
Wed, 08.05.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed
JENA, 8 May 2024
Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior [ … ]
Fri, 09.02.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Decline in profit due to expected weaker product mix
JENA, 9 February 2024
Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%) [ … ]
Mon, 29.01.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jena, 29 January 2024
The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f [ … ]
Thu, 11.01.2024
Carl Zeiss Meditec AG
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.
DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced today tha [ … ]